Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

BTSG vs CSTM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CSTM Captures Overall Composite Edge (64.9 BUY vs 47.2 HOLD), While BTSG Leads 4–2 on Growth & Valuation Pillars

CSTM Overall Winner 6-Pillar Tally: BTSG 4 – 2 CSTM Matrix Metrics: BTSG 3 – 7 CSTM

As of Nov 19, 2026, Constellium SE Class A (CSTM) captures the overall head-to-head institutional edge over BrightSpring Health Services, Inc. (BTSG) on higher Unified Composite conviction (64.9/100 BUY vs. 47.2/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while BTSG wins 4–2 across the 6-pillar growth and valuation breakdown. BTSG trades at $64.02 (26.5x Forward P/E, 3.5% operating margin) versus CSTM at $20.93 (8.1x Forward P/E, 8.6% operating margin).

  • Growth vs. Quality Trade-Off: CSTM earns the overall head-to-head edge with a stronger Unified Composite Score (64.9/100 BUY vs. BTSG 47.2/100 HOLD) and 1.89β · 48% Vol risk profile, whereas BTSG leads top-line expansion (+26.4% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: BTSG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 44.5); meanwhile CSTM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BTSG vs CSTM
BTSG NASDAQ
BrightSpring Health Services, Inc. Common Stock
Services-Home Health Care Services
$64.02
-6.32% 1D
Market Cap $13.6B
TTM Revenue $10.4B
Forward P/E 26.5x
Beta / 30D Vol 0.93β · 58% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 37.0 Fund 47.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 44.5 · SMA20: $66.67 · SMA50: $62.54
CSTM NYSE Head-to-Head Winner
Constellium SE Class A Ordinary shares
Secondary Smelting & Refining Of Nonferrous Metals
$20.93
-2.06% 1D
Market Cap $2.9B
TTM Revenue $10.0B
Forward P/E 8.1x
Beta / 30D Vol 1.89β · 48% Vol
Unified Composite Score
64.9 / 100 BUY
Tech 60.0 Fund 58.0 Flow 61.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.1%), weak momentum, RSI 32
RSI-14: 32.2 · SMA20: $22.65 · SMA50: $24.23

6-Pillar Scorecard Institutional Category Breakdown (BTSG 4 – 2 CSTM)

Columns: Metric · BTSG · CSTM
1. Valuation Multiples CSTM
Forward P/E 26.5x 8.1x
Trailing P/E 48.5x 5.2x
PEG Ratio N/M 0.40x
EV / Revenue 1.4x 0.5x
2. Growth & Scale BTSG
Revenue Growth (YoY) +26.4% +21.8%
Earnings Growth (YoY) +82.0% +35.5%
TTM Revenue (USD) $10.4B $10.0B
Market Cap $13.6B $2.9B
3. Profitability & Quality CSTM
Gross Margin 12.5% 16.3%
Operating Margin 3.5% 8.6%
Net Profit Margin 2.7% 5.7%
Return on Equity (ROE) 15.5% 52.3%
4. Balance Sheet & Cash Flow BTSG
Cash Generation (TTM) $337M $319M
Cash Flow Margin 3.2% 3.2%
Net Cash / Leverage $1.14B Net Debt (1.09x D/E) $1.66B Net Debt (1.36x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BTSG
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 38.5% (18th %ile) 45.8% (21st %ile)
Put/Call OI Skew 2.01x (Put-Skewed) 3.16x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat BTSG
OpEx & R&D Intensity 9.0% of Rev ($939M) 7.7% of Rev ($774M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Health Information Services Operator Aluminum Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BTSG (3) vs CSTM (7)
Institutional Metric BTSG CSTM Criterion Row Edge
Market Capitalization
Scale
$13.6B $2.9B Larger Scale BTSG
Trailing P/E Ratio
Valuation
48.5x 5.2x Lower Multiple CSTM
Forward P/E Ratio
Valuation
26.5x 8.1x Lower Multiple CSTM
Revenue Growth (YoY)
Growth
+26.4% +21.8% Higher Growth BTSG
Operating Margin (TTM)
Profitability
3.5% 8.6% Higher Margin CSTM
Net Profit Margin
Profitability
2.7% 5.7% Higher Margin CSTM
Return on Equity (ROE)
Capital Efficiency
15.5% 52.3% Higher ROE CSTM
52-Week Range Position
Momentum
77% ($31–$74) 28% ($15–$37) Stronger Trend BTSG
Beta / 30D Volatility
Risk Regime
0.93β · 58% Vol 1.89β · 48% Vol Lower Realized Risk CSTM
Unified Institutional Score
Composite Signal
47.2 / 100 (HOLD) 64.9 / 100 (BUY) Higher Composite CSTM
Trailing 12M Revenue (USD)
Operating Scale
$10.4B $10.0B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
12.5% 16.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.4x EV/Rev 0.40x PEG · 0.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$337M ($1.14B Net Debt (1.09x D/E)) $319M ($1.66B Net Debt (1.36x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BTSG +20.84 pp
BTSG: +2.66% · CSTM: -18.18%
3M Horizon BTSG +31.35 pp
BTSG: +8.75% · CSTM: -22.6%
6M Horizon BTSG +45.08 pp
BTSG: +10.4% · CSTM: -34.68%
1Y Horizon BTSG +61.02 pp
BTSG: +102.92% · CSTM: +41.9%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BTSG Revenue CSTM Revenue BTSG Op. Margin CSTM Op. Margin Margin Leader
FY2022 $7.72B $8.53B 2.4% 3.6% CSTM
FY2023 $7.69B $7.83B 0.8% 1.9% CSTM
FY2024 $10.1B $7.33B 1.1% 0.8% BTSG
FY2025 $12.9B $8.45B 2.3% 3.2% CSTM

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BTSG CONSOLIDATION
103d in phase · OBV NEUTRAL
Current IV 38.5%
IV Percentile 18th %ile
Put/Call OI Skew 2.01x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact BTSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CSTM BREAKDOWN
117d in phase · OBV DISTRIBUTION
Current IV 45.8%
IV Percentile 21st %ile
Put/Call OI Skew 3.16x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact CSTM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $69.67 · IV 45.1%

BTSG Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($6,967)

Compare $6,967 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 45.1% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $70 / $75 Bull Call Spread

Buy 1x $70C · Sell 1x $75C · 31d

Net Entry $253 Debit
T+5d @ +5% Move +$58 (+23%)
Max Risk / Buffer $253 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $65 / $60 Bull Put Spread

Sell 1x $65P · Buy 1x $60P · 59d

Net Entry $70 Credit
Max Credit / Yield +$70 (+16.3% RoM)
Max Risk / Buffer -7.7% Cushion ($430 Mgn)
5d Edge & Liquidity 72% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BTSG Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $13.6B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 9.0% of Rev ($939M)
90D Engineering Disclosures 0 Published
CSTM Moat Profile High-Margin Pricing Power Moat
Aluminum Operator
Competes within the Aluminum value chain with $2.9B market capitalization and 8.6% operating margin.
OpEx & R&D Reinvestment 7.7% of Rev ($774M)
90D Engineering Disclosures 0 Published

Investor FAQ BTSG vs CSTM Key Questions & Quantitative Answers

As of Nov 19, 2026, Constellium SE Class A (CSTM) captures the overall head-to-head institutional edge over BrightSpring Health Services, Inc. (BTSG) on higher Unified Composite conviction (64.9/100 BUY vs. 47.2/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while BTSG wins 4–2 across the 6-pillar growth and valuation breakdown. BTSG trades at $64.02 (26.5x Forward P/E, 3.5% operating margin) versus CSTM at $20.93 (8.1x Forward P/E, 8.6% operating margin). Growth vs. Quality Trade-Off: CSTM earns the overall head-to-head edge with a stronger Unified Composite Score (64.9/100 BUY vs. BTSG 47.2/100 HOLD) and 1.89β · 48% Vol risk profile, whereas BTSG leads top-line expansion (+26.4% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BTSG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 44.5); meanwhile CSTM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BTSG leads the Growth & Scale pillar: BTSG posts +26.4% YoY revenue growth and +82.0% YoY earnings growth on $10.4B TTM revenue (12.5% gross margin, 3.5% operating margin), compared with CSTM at +21.8% YoY revenue growth and +35.5% YoY earnings growth on $10.0B TTM revenue (16.3% gross margin, 8.6% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), BTSG cumulative revenue shifted +67.2% while CSTM shifted -0.9%. In operating R&D and SG&A reinvestment, BTSG deploys 9.0% of Rev ($939M) (0 90-day corporate R&D disclosures) versus 7.7% of Rev ($774M) (0 disclosures) for CSTM.

CSTM screens cheaper on headline valuation multiples. BTSG trades at 26.5x Forward P/E, 48.5x Trailing P/E, N/M PEG, and 1.4x EV/Revenue (3.2% FCF margin), whereas CSTM trades at 8.1x Forward P/E, 5.2x Trailing P/E, 0.40x PEG, and 0.5x EV/Revenue (3.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BTSG (15.5% ROE) versus CSTM (52.3% ROE) capital efficiency.

In options market volatility and institutional positioning, BTSG carries 38.5% implied volatility (18th %ile, Compressed (<25th %ile)), a 2.01x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.93β · 58% Vol realized risk). By comparison, CSTM carries 45.8% implied volatility (21st %ile, Compressed (<25th %ile)), a 3.16x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.89β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.